Journament

Keyword Connections - Rheumatoid Arthritis Keywords

Connection Type	Connection
Journals	Nutrients Frontiers in pharmacology PloS one The Biochemical journal European journal of pharmacology International journal of molecular sciences Journal of human genetics nanomedicine (london, england) journal of clinical medicine bmc musculoskeletal disorders Biomaterials science Trials The Journal of investigative dermatology Frontiers in bioengineering and biotechnology Lancet (London, England) computer methods and programs in biomedicine Health technology assessment (Winchester, England) arthritis care & research annals of the rheumatic diseases the pharmacogenomics journal Nature nature genetics arthritis research & therapy ophthalmology rheumatology (oxford, england) American journal of human genetics journal of healthcare engineering Clinical rheumatology Drug design, development and therapy Journal of molecular biology annales de dermatologie et de venereologie Respiratory medicine advances in experimental medicine and biology Journal of the Medical Association of Thailand = Chotmaihet thangphaet modern rheumatology international journal of rheumatic diseases journal of the international academy of periodontology autoimmunity reviews journal of dermatological science Advances in clinical and experimental medicine : official organ Wroclaw Medical University journal of medical economics amyloid : the international journal of experimental and clinical investigation : the official journal of the international society of amyloidosis iranian journal of allergy, asthma, and immunology joint bone spine current opinion in pulmonary medicine pharmacological reviews open access rheumatology : research and reviews
Research Groups	No Research Group Connected
Bibliographies	[1] Prevalence of feet and ankle arthritis and their impact on clinical indices in patients with rheumatoid arthritis: a cross-sectional study. [2] Macrophage M1/M2 polarization and rheumatoid arthritis: A systematic review. [3] Clinico-genetic model to predict methotrexate intolerance in rheumatoid arthritis. [4] Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias. [5] The potential value of rapid, cloud-enabled onsite testing for the diagnosis of rheumatoid arthritis in the United States. [6] Automated Risk Control in Medical Imaging Equipment Management Using Cloud Application. [7] First Validation of the Full PROMIS Pain Interference and Pain Behavior Item Banks in Patients with Rheumatoid Arthritis. [8] Are we really what we eat? Nutrition and its role in the onset of rheumatoid arthritis. [9] Methotrexate Restores CD73 Expression on Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis Patients and May Contribute to Its Anti-Inflammatory Effect through Ado Production. [10] What potential do magnetic iron oxide nanoparticles have for the treatment of rheumatoid arthritis? [11] Magnetic thermosensitive micelles with upper critical solution temperature for NIR triggered drug release. [12] Synovial tissue quantitative proteomics analysis reveals paeoniflorin decreases LIFR and ASPN proteins in experimental rheumatoid arthritis. [13] Patient profile with ATTR-FAP and evaluation of the safety and efficacy of tafamidis meglumine in Japan - interim analysis in post-marketing surveillance. [14] REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics. [15] Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations. [16] A reliable time-series method for predicting arthritic disease outcomes: New step from regression toward a nonlinear artificial intelligence method. [17] Comparative Price Analysis of Biological Products for Treatment of Rheumatoid Arthritis. [18] Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications. [19] Impact of pharmacist educational intervention on disease knowledge, rehabilitation and medication adherence, treatment-induced direct cost, health-related quality of life and satisfaction in patients with rheumatoid arthritis: study protocol for a randomized controlled trial. [20] Clinical Improvements as Predictors of Improvements in Patient-Reported Outcomes: Post Hoc Analysis of a Randomized, Open-Label Study of Etanercept in Latin American Patients with Rheumatoid Arthritis. [21] Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan. [22] Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: a population-based study in the first two months of COVID-19 outbreak in Italy. [23] Energy Conversion-Based Nanotherapy for Rheumatoid Arthritis Treatment. [24] The Relationship between Hematological Markers of Systemic Inflammation (Neutrophil-To-Lymphocyte, Platelet-To-Lymphocyte, Lymphocyte-To-Monocyte Ratios) and Ultrasound Disease Activity Parameters in Patients with Rheumatoid Arthritis [25] Prospective assessment of cardiovascular risk parameters in patients with rheumatoid arthritis. [26] Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis [27] The Relationship between Hematological Markers of Systemic Inflammation (Neutrophil-To-Lymphocyte, Platelet-To-Lymphocyte, Lymphocyte-To-Monocyte Ratios) and Ultrasound Disease Activity Parameters in Patients with Rheumatoid Arthritis [28] Effects of upadacitinib on patient-reported outcomes: results from SELECT-BEYOND, a phase 3 randomized trial in patients with rheumatoid arthritis and inadequate responses to biologic disease-modifying antirheumatic drugs [29] Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis [30] a novel jak inhibitor, peficitinib, demonstrates potent efficacy in a rat adjuvant-induced arthritis model [31] episclerite e esclerite episcleritis and scleritis [32] matrix metalloproteinase 2, 3, and 9 gene polymorphisms in women with rheumatoid arthritis [33] phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations [34] hand to mouth: a systematic review and meta-analysis of the association between rheumatoid arthritis and periodontitis [35] promotion of osteoclastogenesis by il-26 in rheumatoid arthritis [36] eight-year preservation of knee function with radiographic healing phenomena after anti-tumor necrosis factor-α therapy for a severely erosive knee in a young patient with rheumatoid arthritis [37] efficacy and safety of sarilumab in combination with csdmards or as monotherapy in subpopulations of patients with moderately to severely active rheumatoid arthritis in three phase iii randomized, controlled studies [38] rheumatoid arthritis in patients with hiv: management challenges [39] bronchopulmonary lesions and quality of life in patients with rheumatoid arthritis [40] modeling using clinical examination indicators predicts interstitial lung disease among patients with rheumatoid arthritis [41] the macrophage mannose receptor regulate mannan-induced psoriasis, psoriatic arthritis, and rheumatoid arthritis-like disease models [42] managing rheumatoid arthritis with dietary interventions [43] alpha–2–macroglobulin complexes with igg antibodies, plasmin, and their interrelation with other factors of humoral immunity during the development of rheumatoid arthritis [44] the effects of orally administered bacillus coagulans and inulin on prevention and progression of rheumatoid arthritis in rats [45] commentary: rheumatoid cachexia revisited: a metabolic co-morbidity in rheumatoid arthritis [46] intravenous pamidronate for refractory rheumatoid arthritis [47] protective role of the mer tyrosine kinase via efferocytosis in rheumatoid arthritis models [48] magnetic resonance imaging versus musculoskeletal ultrasound in the evaluation of temporomandibular joint in rheumatoid arthritis patients [49] abnormal directed migration of blood polymorphonuclear leukocytes in rheumatoid arthritis. potential role in increased susceptibility to bacterial infections [50] association study of aff1 rs340630 polymorphism with genetic susceptibility to rheumatoid arthritis in chinese population [51] the economic burden of musculoskeletal disorders on the italian social security pension system estimated by a monte carlo simulation [52] the petroleum ether fraction of celastrus paniculatus willd. seeds demonstrates anti-arthritic effect in adjuvant-induced arthritis in rats [53] identification of novel protein kinase receptor type 2 inhibitors using pharmacophore and structure-based virtual screening [54] the assessment of cardiac sempathovagal activity by heart rate variability in patients with rheumatoid arthritis [55] wu-tou decoction in rheumatoid arthritis: integrating network pharmacology and in vivo pharmacological evaluation [56] effect of infliximab dose increase in rheumatoid arthritis at different trough concentrations: a cohort study in clinical practice conditions [57] netosis as source of autoantigens in rheumatoid arthritis [58] rheumatoid arthritis: what do mri and ultrasound show [59] corneal, scleral, choroidal, and foveal thickness in patients with rheumatoid arthritis [60] systemic vasculitis in a patient with rhupus syndrome [61] therapeutic antibody-like immunoconjugates against tissue factor with the potential to treat angiogenesis-dependent as well as macrophage-associated human diseases [62] Cardamonin (2',4'-dihydroxy-6'-methoxychalcone) isolated from Boesenbergia rotunda (L.) Mansf. inhibits CFA-induced rheumatoid arthritis in rats. [63] Cytotoxic and Anti-inflammatory Activities of Medicinal Plants and Women’s Health Remedy Found in “Mahachotarat Scripture” of Thai Traditional Medicine. [64] Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer’s disease in patients with rheumatoid arthritis and psoriasis [65] Pathogenic or Therapeutic Extracellular Vesicles in Rheumatic Diseases: Role of Mesenchymal Stem Cell-Derived Vesicles [66] Increased Risk of Temporomandibular Joint Disorder in Patients with Rheumatoid Arthritis: A Longitudinal Follow-Up Study [67] TNF-alpha, IL-6, IL-10 and fatty acids in rheumatoid arthritis patients receiving cDMARD and bDMARD therapy. [68] Does Pizza Consumption Favor an Improved Disease Activity in Rheumatoid Arthritis? [69] Computational analysis to investigate the anti-rheumatic potential of plant-based small molecule inhibitor targeting tumor necrosis factor . [70] Impact of psychological factors on subjective disease activity assessments in patients with severe rheumatoid arthritis. [71] Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort. [72] High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. [73] Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort. [74] Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. [75] PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population. [76] Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13. [77] A Comparative Study of Interleukin 6, Inflammatory Markers, Ferritin, and Hematological Profile in Rheumatoid Arthritis Patients with Anemia of Chronic Disease and Iron Deficiency Anemia [78] Galectin-1, -4, and -7 Were Associated with High Activity of Disease in Patients with Rheumatoid Arthritis [79] Concordance between the Different Cardiovascular Risk Scores in People with Rheumatoid Arthritis and Psoriasis Arthritis [80] Medication Adherence and Coping Strategies in Patients with Rheumatoid Arthritis: A Cross-Sectional Study [81] Occipital and external acoustic meatus to axis angle: a useful predictor of oropharyngeal space in rheumatoid arthritis patients with atlantoaxial subluxation. [82] Association between plasminogen activator inhibitor‑1 (PAI-1) 4G/5G polymorphism and circulating PAI-1 level in systemic lupus erythematosus and rheumatoid arthritis : A meta-analysis. [83] QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS - A PRELIMINARY STUDY. [84] Vitamin D Receptor Polymorphism and DHCR7 Contribute to the Abnormal Interplay Between Vitamin D and Lipid Profile in Rheumatoid Arthritis [85] Renal function and cardiovascular risk in rheumatoid arthritis [86] Respiratory viral infections and the risk of rheumatoid arthritis. [87] Prevalence of methotrexate intolerance among patients with rheumatoid arthritis using the Arabic version of the methotrexate intolerance severity score. [88] Crosstalk between Fas and S1P<inf>1</inf> signaling via NF-kB in osteoclasts controls bone destruction in the TMJ due to rheumatoid arthritis [89] Assessment of interstitial lung disease among black rheumatoid arthritis patients. [90] Potential mechanisms linking periodontitis to rheumatoid arthritis. [91] Machine-learning based knowledge discovery in rheumatoid arthritis related registry data to identify predictors of persistent pain. [92] Characterization of rheumatoid arthritis subtypes using symptom profiles, clinical chemistry and metabolomics measurements. [93] Affinity maturation shapes the function of agonistic antibodies to peptidylarginine deiminase type 4 in rheumatoid arthritis. [94] Antibodies directed against endogenous and exogenous citrullinated antigens pre-date the onset of rheumatoid arthritis. [95] Polymorphisms in peptidylarginine deiminase associate with rheumatoid arthritis in diverse Asian populations: evidence from MyEIRA study and meta-analysis. [96] Effectiveness of subcutaneously administered methotrexate in patients with rheumatoid arthritis. [97] Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: multi-center retrospective descriptive study. [98] Efficacy and Safety of Multiple Dosages of Fostamatinib in Adult Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. [99] No increase in the risk of autism spectrum disorder in children born to mothers with systemic lupus erythematosus and rheumatoid arthritis [100] Investigation of the cytokine response to NF-ΚB decoy oligonucleotide coated polysaccharide based nanoparticles in rheumatoid arthritis in vitro models [101] Proteomics Approach for the Discovery of Rheumatoid Arthritis Biomarkers Using Mass Spectrometry.